Issues in experimental design and endpoint analysis in the study of experimental cytotoxic agents in vivo in breast cancer and other models

Author： Clarke R.  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.46, Iss.2-3, 1997-11, pp. : 255-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Animal models of breast cancer: experimental design and their use in nutrition and psychosocial research

By Clarke R.  

Breast Cancer Research and Treatment, Vol. 46, Iss. 2-3, 1997-11 ,pp. : 117-133

Springer Publishing Company

Access to resources Recommend Favorite

Design and Synthesis of Some Novel Estrogen Receptor Modulators as Anti-Breast Cancer Agents: In Vitro In Vivo Screening, Docking Analysis

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 11, 2016-10 ,pp. : 1461-1467

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical approaches to experimental design and data analysis of in vivo studies

By Hanfelt J.J.  

Breast Cancer Research and Treatment, Vol. 46, Iss. 2-3, 1997-11 ,pp. : 279-302

Springer Publishing Company

Access to resources Recommend Favorite

Experimental basis for the prevention of breast cancer

By Mehta R.G.  

European Journal of Cancer, Vol. 36, Iss. 10, 2000-06 ,pp. : 1275-1282

Elsevier

Access to resources Recommend Favorite

The Experimental Antitumor Agents Phortress and Doxorubicin are Equiactive Against Human‐Derived Breast Carcinoma Xenograft Models

By Fichtner Iduna  

Breast Cancer Research and Treatment, Vol. 87, Iss. 1, 2004-09 ,pp. : 97-107

Springer Publishing Company

Access to resources Recommend Favorite